Structural Insights into Binding of the Antifungal Drug Fluconazole to Saccharomyces cerevisiae Lanosterol 14-Demethylase (original) (raw)
Structural Insights into Binding of the Antifungal Drug Fluconazole to Saccharomyces cerevisiae Lanosterol 14α-Demethylase
Joel Tyndall
Antimicrobial Agents and Chemotherapy, 2015
View PDFchevron_right
Crystal Structures of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provide Tools for Antifungal Discovery
Mikhail Keniya
Antimicrobial Agents and Chemotherapy
View PDFchevron_right
Crystal structure of the new investigational drug candidate VT-1598 in complex with Aspergillus fumigatus sterol 14α-demethylase provides insights into its broad-spectrum antifungal activity
Girish Rachakonda
Antimicrobial agents and chemotherapy, 2017
View PDFchevron_right
Molecular design of two sterol 14α-demethylase homology models and their interactions with the azole antifungals ketoconazole and bifonazole
Bernd Rupp
Journal of Computer-Aided Molecular Design, 2005
View PDFchevron_right
Structural Characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei Bound to the Antifungal Drugs Posaconazole and Fluconazole
Mathew Jacobson
PLoS Neglected Tropical Diseases, 2010
View PDFchevron_right
Structural alterations to counter multi-drug resistance in azoles
Tapan Mukherjee, Parth Malik
View PDFchevron_right
Three-Dimensional Model of Lanosterol 14 -Demethylase from Cryptococcus neoformans: Active-Site Characterization and Insights into Azole Binding
Guozhu Dong
Antimicrobial Agents and Chemotherapy, 2009
View PDFchevron_right
Three-dimensional models of 14α-sterol demethylase (Cyp51A) from Aspergillus lentulus and Aspergillus fumigatus: an insight into differences in voriconazole interaction
Dominique Sanglard
International Journal of Antimicrobial Agents, 2011
View PDFchevron_right
Azole Resistance Reduces Susceptibility to the Tetrazole Antifungal VT-1161
Mikhail Keniya
Antimicrobial Agents and Chemotherapy
View PDFchevron_right
Antifungal screening and in silico mechanistic studies of an in-house azole library
ARZU KARAKURT
Chemical Biology & Drug Design, 2019
View PDFchevron_right
Heterologous expression of full-length lanosterol 14α-demethylases of prominent fungal pathogens Candida albicans and Candida glabrata provides tools for antifungal discovery
Mikhail Keniya
Antimicrobial Agents and Chemotherapy, 2018
View PDFchevron_right
Relationship of Azole Resistance with the Structural Alteration of the Target Sites: Novel Synthetic Compounds for Better Antifungal Activities
Ram Kumar, Tapan Mukherjee, Parth Malik
The Natural Products Journal, 2014
View PDFchevron_right
Amino Acid Substitutions at the Major Insertion Loop of Candida albicans Sterol 14alpha-Demethylase Are Involved in Fluconazole Resistance
Florent Morio
PLoS ONE, 2011
View PDFchevron_right
Crystal Structure of the Mycobacterium tuberculosis P450 CYP121-Fluconazole Complex Reveals New Azole Drug-P450 Binding Mode
Kirsty McLean
Journal of Biological Chemistry, 2006
View PDFchevron_right
Structural and Functional Elucidation of Yeast Lanosterol 14α-Demethylase in Complex with Agrochemical Antifungals
Mikhail Keniya
PloS one, 2016
View PDFchevron_right
Fluconazole binding and sterol demethylation in three CYP51 isoforms indicate differences in active site topology
Galina Lepesheva
The Journal of Lipid Research, 2004
View PDFchevron_right
In silico Discovery of a New Potent Inhibitor for Sterol 14-alpha Demethylase as a Promising Antifungal Drug against Aspergillus fumigatus Infection
Hayder O Hashim
Biointerface Research in Applied Chemistry, 2021
View PDFchevron_right
The amino acid substitution N136Y in Candida albicans sterol 14alpha-demethylase is involved in fluconazole resistance
Audrey FLEURY
Medical mycology, 2016
View PDFchevron_right
Structural Insights into the Azole Resistance of the Candida albicans Darlington Strain Using Saccharomyces cerevisiae Lanosterol 14α-Demethylase as a Surrogate
Mikhail Keniya
Journal of Fungi
View PDFchevron_right
Structural Basis of Human CYP51 Inhibition by Antifungal Azoles
Sergey Usanov
Journal of Molecular Biology, 2010
View PDFchevron_right
Real-Time Imaging of the Azole Class of Antifungal Drugs in Live Candida Cells
Yael Roichman
ACS chemical biology, 2017
View PDFchevron_right
Fluconazole-Like Compounds as Potential Antifungal Agents: QSAR, Molecular Docking, and Molecular Dynamics Simulation
Razieh Sabet
Journal of Chemistry, 2022
View PDFchevron_right
The Mutation T315A in Candida albicans Sterol 14α-Demethylase Causes Reduced Enzyme Activity and Fluconazole Resistance through Reduced Affinity
muhammad saeed Akhtar
Journal of Biological Chemistry, 1997
View PDFchevron_right
Molecular Modeling of Azole Antifungal Agents Active against Candida albicans. 1. A Comparative Molecular Field Analysis Study1
Roberto Di Santo
View PDFchevron_right
Structure-based rational design, synthesis and antifungal activity of oxime-containing azole derivatives
Guozhu Dong
Bioorganic & Medicinal Chemistry Letters, 2010
View PDFchevron_right
Bioisosterism based Design, Synthesis and Antifungal Evaluation of Novel Fluconazole Analogues
Sunita Surse
Asian Journal of Chemistry
View PDFchevron_right
Amino Acid Substitutions in the Cytochrome P-450 Lanosterol 14α-Demethylase (CYP51A1) from Azole-Resistant Candida albicans Clinical Isolates Contribute to Resistance to Azole Antifungal Agents
Dominique Sanglard
Antimicrobial Agents and Chemotherapy, 1998
View PDFchevron_right
Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole
Jan Wildenhain
Molecular systems biology, 2011
View PDFchevron_right
ML212: A small-molecule probe for investigating fluconazole resistance mechanisms in Candida albicans
Michelle Palmer
Beilstein Journal of Organic Chemistry, 2013
View PDFchevron_right
In Silico Structural Modeling and Analysis of Interactions of Tremellomycetes Cytochrome P450 Monooxygenases CYP51s with Substrates and Azoles
Justyna Kryś
International Journal of Molecular Sciences
View PDFchevron_right